Ratings by Bloom Burton & Co.
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/9/2026 | David Martin | Xenon Pharmaceuticals | XENE | Maintain | Buy (1) (N/A) |
74.00 (56.00) |
|
Details | |
| 2/24/2026 | David Martin | Eupraxia Pharmaceuticals | EPRX | New Coverage | Buy (1) (N/A) |
14.00 (N/A) |
8.50 (6.03) |
-29.06% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 8 more... | |||||||||
